Richard R. DeLuca, Jr
EVP&Pres, Merck Animal Heallth at Merck & Co.. Based in Rahway, New Jersey.
- Rank
- 6319th of 14,452
- Companies held
- 1
- Largest holding
- MRK, 100.0% of total
- Latest SEC filing
- Nov 12, 2026
What the $15.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Merck & Co. MRK Common Stock | Directly | 112,955 | $132.81 | $15.0M | 97.7% | Form 4, Nov 12, 2026 |
| Merck & Co. MRK Common Stock - 401(k) Plan | Through 401(k) | 1,336 | $132.81 | $177K | 1.2% | Form 4, Nov 12, 2026 |
| Merck & Co. MRK Common Stock - 401(k) Plan | Indirectly (see filing footnote) | 1,321 | $132.81 | $175K | 1.1% | Form 4, May 5, 2026 |
Share counts are the amounts Richard R. DeLuca, Jr reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Sold | MRK | 58,185 | $148.01 | $8.6M | View |
| Aug 12, 2026 | Sold | MRK | 11,099 | $131.61 | $1.5M | View |
| Aug 12, 2026 | Sold | MRK | 600 | $132.04 | $79K | View |
| Aug 11, 2026 | Sold | MRK | 7,410 | $131.33 | $973K | View |
| Aug 11, 2026 | Sold | MRK | 5,427 | $132.35 | $718K | View |
| Aug 10, 2026 | Sold | MRK | 20,784 | $130.43 | $2.7M | View |
| Aug 6, 2026 | Sold | MRK | 805 | $131.02 | $105K | View |
| Aug 6, 2026 | Sold | MRK | 300 | $131.02 | $39K | View |
| Aug 6, 2026 | Sold | MRK | 4,945 | $130.23 | $644K | View |
| Feb 6, 2026 | Sold | MRK | 37,685 | $120.92 | $4.6M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6316 | Karen L. Parkhill EVP & Chief Financial Officer, Medtronic. Palo Alto, CA | $15.4M |
| 6317 | George M. Schisler Chief Legal Officer, Lam Research. Fremont, CA | $15.4M |
| 6318 | Edward F. Barry Chief Executive Officer, Capital Bancorp. Rockville, MD | $15.4M |
| 6319 | Richard R. DeLuca, Jr EVP&Pres, Merck Animal Heallth, Merck & Co.. Rahway, NJ | $15.4M |
| 6320 | Dean Kamen Director, BETA Technologies. South Burlington, VT | $15.4M |
| 6321 | Calvin McDonald Chief Executive Officer, lululemon athletica. Burbank, CA | $15.3M |
| 6322 | Desmond Lynch Chief Financial Officer, Astera Labs. San Jose, CA | $15.3M |
Other Merck & Co. insiders
All MRK insiders- Kenneth C. Frazier$94.2MExecutive Chair. #1562 overall
- Robert M. Davis$59.8MChairman, CEO & President. #2189 overall
- Sanat Chattopadhyay$34.3MExe V-P & Pres. MMD. #3391 overall
- Dean Y. Li$12.5MExecutive VP & President, MRL. #4832 overall
- Caroline Litchfield$12.3MEVP & CFO. #7541 overall
- Julie L. Gerberding$6.5MEVP, Chief Patient Officer. #12086 overall
Questions
How much stock does Richard R. DeLuca, Jr own?
Richard R. DeLuca, Jr holds $15,354,479 in listed stock based on SEC filings and current prices, mostly Merck & Co. (MRK). That ranks 6319th on the Stock Rich List.
Is this Richard R. DeLuca, Jr's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Richard R. DeLuca, Jr last buy or sell stock?
The most recent open-market trade on file is a sale of 58,185 MRK shares on Nov 12, 2026 at $148.01.